Loading ...
the multiple pathwaysleadingto platelet activation
the signaling pathwaysleadto platelet activation
intracellular signal transduction pathwaysresultin platelet activation
many pathwaysleadingto platelet activation
intracellular pathwaysleadingto platelet activation
classical pathwaysleadingto platelet activation
several pathwaysleadingto platelet activation
different signalling pathwayscontributeto platelet activation
Many agonistsleadto platelet activation
the several signal transduction pathwaysleadingto platelet activation
the addition of brazilin or various agoniststo triggerplatelet activation
platelets ... adhesion receptorsleadto platelet activation
the specific downstream pathways of VPS34 signalingleadingto platelet activation
different agonists ( Figure 1C(passive) triggered byplatelet activation
interactions between platelets and collagenresultin platelet activation
an organized signaling cascadeleadsto platelet activation
agonists such as thrombin or by contact with the extracellular matrix(passive) caused byPlatelet activation
a sequence of eventsresultsin platelet activation
thromboxane A2-independent pathways , such as adenosine diphosphate or thrombin(passive) caused byplatelet activation
Simultaneous binding of these antibodies to Fc receptors on the platelet surfacecausesplatelet activation
vivo evidenceleadsto platelet activation
stimulating platelets in a platelet sampleto causeactivation of the platelets
the platelets ... in turnleadsto platelet activation
platelets and bacterialeadingto platelet activation
platelets ... the subendotheliumleadsto platelet activation
virions and plateletsleadingto platelet activation
A number of physiological agonistscan causeplatelet activation
either von Willebrand factor interactions with GP Ibα and GP IIb - IIIa[1–4(passive) triggered byplatelet activation
All the platelet agonists , either directly or indirectly , depend on G protein pathwaysto causeplatelet activation
alpha-6-fucosyltransferase ... thrombin or other agonistscauseplatelet activation
an intracellular signaling pathwayresultingin platelet activation
the intracellular signalscontributeto platelet activation
contact of collagen ( of the plaques extracellular matrix ... the bloodcan triggerplatelet activation
several agonists including ADP , thromboxane A2 , collagen , thrombin , epinephrine and others(passive) is caused byPlatelet activation
a broad variety of events(passive) is caused byPlatelet activation
that promotes thrombinsignaling leadingto platelet activation
intracellular processesleadingto platelet activation
Both processes are believedto contributeto platelet activation
When present , these antibodies bind to the heparin / PF4 complex on the surface of platelets and crosslink Fc receptors on the platelet surfacethereby causingplatelet activation
ADP and the von Willebrand factor(passive) is triggered byPlatelet activation
to platelet aggregation and clotleadingto platelet aggregation and clot
platelet aggregation and adhesion to the blood vessel wallpreventingplatelet aggregation and adhesion to the blood vessel wall
to optimal thrombus formationleadingto optimal thrombus formation
to arterial thrombus formationleadsto arterial thrombus formation
in decreased tendency of platelets to adhere to one another and to damaged blood vessels endothelium.[2 ] 4.1 Prevention and treatment of arterial thrombosis 5 Dental Management of Patients on Antiplatelet Drugs 5.1 Assessresultingin decreased tendency of platelets to adhere to one another and to damaged blood vessels endothelium.[2 ] 4.1 Prevention and treatment of arterial thrombosis 5 Dental Management of Patients on Antiplatelet Drugs 5.1 Assess
to whacking great platelet aggregationleadsto whacking great platelet aggregation
in platelet aggregation , Neuropathology , Supercentenarian , Tauresultedin platelet aggregation , Neuropathology , Supercentenarian , Tau
to platelet aggregation and formation of a primary hemostatic plugleadsto platelet aggregation and formation of a primary hemostatic plug
to clot formation and thrombosisleadingto clot formation and thrombosis
to the link between depression , thrombus formation , and haemostasismay contributeto the link between depression , thrombus formation , and haemostasis
to enhanced aggregation and thrombosis [ 7leadingto enhanced aggregation and thrombosis [ 7
to fibrinogen cross - linking of platelets and platelet aggregationleadingto fibrinogen cross - linking of platelets and platelet aggregation
to thrombus formation on medical device surfacesleadsto thrombus formation on medical device surfaces
to a conformational shape change of the platelet , thrombin generation , and platelet aggregationleadsto a conformational shape change of the platelet , thrombin generation , and platelet aggregation
to increased thrombosisleadingto increased thrombosis
to thrombosis and embolizationleadingto thrombosis and embolization
to change in platelet size , platelet shape , platelet aggregationleadsto change in platelet size , platelet shape , platelet aggregation
in platelet aggregation | Identification and Characterization of Inhibitors of Human Apurinicresultedin platelet aggregation | Identification and Characterization of Inhibitors of Human Apurinic
in platelet aggregation ... but it is blocked by anti - Fc receptor CD32resultedin platelet aggregation ... but it is blocked by anti - Fc receptor CD32
to their aggregation and clot formationleadsto their aggregation and clot formation
to secretion and supports platelet aggregation thereby protecting against bleeding during inflammationleadsto secretion and supports platelet aggregation thereby protecting against bleeding during inflammation
a cascade of further platelet activation eventually causing the formation of the thrombus.[1 ] This process is regulated through thromboregulationcausesa cascade of further platelet activation eventually causing the formation of the thrombus.[1 ] This process is regulated through thromboregulation
in less thrombus formation or clotting in catheter - based productsresultingin less thrombus formation or clotting in catheter - based products
to activation and propagation of the complement system | Journal ofleadsto activation and propagation of the complement system | Journal of
to the clinical manifestations of thrombocytopenia and thrombosisleadsto the clinical manifestations of thrombocytopenia and thrombosis
Particularly , arterial thrombosis is considered(passive) to be triggered byParticularly , arterial thrombosis is considered
p1442 Individuals with mechanical heart valve implants(passive) are ... caused byp1442 Individuals with mechanical heart valve implants
to conformational changes in the structure of integrin β3 , which enhances platelet aggregation [ 25leadsto conformational changes in the structure of integrin β3 , which enhances platelet aggregation [ 25
to conformational changes in the structure of integrin αⅡbβ3 , which enhances platelet aggregation[27leadsto conformational changes in the structure of integrin αⅡbβ3 , which enhances platelet aggregation[27
to up - regulation of PrPc not only on CD55 + but surprisingly also on CD55−plateletsledto up - regulation of PrPc not only on CD55 + but surprisingly also on CD55−platelets
to dangerous blood clottingcan leadto dangerous blood clotting
to activation and propagation of the complement system del Condeleadsto activation and propagation of the complement system del Conde
to a hypercoagulable stateleadsto a hypercoagulable state
1442 - 1450 Individuals with mechanical heart valve implants(passive) are ... caused by1442 - 1450 Individuals with mechanical heart valve implants
in the form of degranulation and adhesionleadsin the form of degranulation and adhesion
to thrombosis but not essential for hemostasiscontributingto thrombosis but not essential for hemostasis
in thrombosis [ 10 - 12resultingin thrombosis [ 10 - 12
in platelet aggregation | Comparison of the Cancer Gene Targeting and Biochemical Selectivities Supplementary MaterialsSupporting Informationresultedin platelet aggregation | Comparison of the Cancer Gene Targeting and Biochemical Selectivities Supplementary MaterialsSupporting Information
to activation and propagation of the complement system | JEM jem Homeleadsto activation and propagation of the complement system | JEM jem Home
in platelet degranulation and aggregationfinally resultingin platelet degranulation and aggregation